Because of its less distinctive biological features [141], HGBCL with MYC and BCL6 rearrangements, regarded as a provisional entity in ICC, is considered in the WHO-HAEM5 as a genetic subtypes of DLBCL, NOS and HGBCL, NOS, respectively. The gene discussed is BCL6; the disease is intrahepatic cholangiocarcinoma.